Angelina Jolie's Cancer Genes: Expert Calls for Routine Prostate Screening

Men carrying the BRCA1 or BRCA2 gene mutations, like Angelina Jolie, should undergo routine prostate screening from the age of 40, according to the Institute for Cancer Research. This, in turn, could detect prostate cancer earlier, when treatment is more effective. The institute recommends annual NHS checks for this high-risk group, using prostate-specific antigen blood tests.

Key Takeaways:

• The Institute for Cancer Research recommends annual prostate-specific antigen (PSA) blood tests for men with BRCA1 or BRCA2 gene mutations starting at age 40.
• Men with these genetic abnormalities are three times as likely to develop aggressive prostate cancer and at a younger age.
• Angelina Jolie had both breasts removed due to her BRCA1 gene mutation, and experts now advocate for proactive measures to address prostate cancer risk.
• Professor Ros Eeles suggests that targeted PSA screening in this high-risk group could improve cancer detection and treatment outcomes.
• Professor Clare Isacke emphasizes the importance of early detection in increasing the chance of a cure, as rates of prostate cancer continue to rise.

Statistics:

• 1 in 8 men will develop prostate cancer in their lifetime[1]
• Men with BRCA1 or BRCA2 gene mutations are 3 times as likely to develop aggressive prostate cancer[2]
• Prostate cancer is the most common form of cancer in men
• Annual prostate-specific antigen (PSA) blood tests are recommended for men with BRCA1 or BRCA2 gene mutations starting at age 40

Sources:

• Institute for Cancer Research
• [1] Cancer Research UK
• [2] World Health Organization